News

The increasing prevalence of antimicrobial resistance (AMR), which the World Health Organization (WHO) defines as the ability of a microorganism – like bacteria, viruses and some parasites – to stop an antimicrobial (such as antibiotics, antivirals and antimalarials) from working against it" (1) is a serious threat to global public health and disproportionately burdens low-resource countries (2, 3). The growing resistance to antibiotics of bacterial pathogens is recognized as the largest of these threats (4). The importance of diagnostics in efforts to combat AMR has also been recognized (5). In particular, there is a need to stimulate the development of, and access to, appropriate rapid diagnostic tools for bacterial pathogen identification (ID) as well as antimicrobial susceptibility testing (AST) at all levels of the healthcare system in low- and middleincome countries (LMICs)."